Mesalamine (Mesalazine)
1173
relevant articles (303 outcomes,
211 trials/studies)
found for this Drug
Description:
An anti-inflammatory agent, structurally related to the SALICYLATES, which is active in INFLAMMATORY BOWEL DISEASE. It is considered to be the active moiety of SULPHASALAZINE. (From Martindale, The Extra Pharmacopoeia, 30th ed)
Also Known As:
Mesalazine; Canasa; Pentasa; Rowasa; 5 Aminosalicylic Acid; 5-Aminosalicylic Acid; Allphar Brand of Mesalamine; Antigen Brand of Mesalamine; Asacol; Asacolon; Ascolitin; Axcan Brand of Mesalamine; Byk Brand of Mesalamine; Celltech Brand of Mesalamine; Claversal; Falk Brand of Mesalamine; Farmasa Brand of Mesalamine; Ferring Brand of Mesalamine; Fivasa; GlaxoSmithKline Brand of Mesalamine; Henning Berlin Brand of Mesalamine; Lixacol; Merckle Brand of Mesalamine; Mesalamine Hydrochloride; Mesalamine Monosodium Salt; Mesasal; Norgine Brand of Mesalamine; Novo-5 ASA; Novopharm Brand of Mesalamine; Procter & Gamble Brand of Mesalamine; Provalis Brand of Mesalamine; Salofalk; Sanofi Synthelabo Brand of Mesalamine; Schering-Plough Brand of Mesalamine; SmithKline Brand of Mesalamine; Solvay Brand of Mesalamine; Yamanouchi Brand of Mesalamine; m-Aminosalicylic Acid; meta-Aminosalicylic Acid; 5 Aminosalicylate; Hydrochloride, Mesalamine; Monosodium Salt, Mesalamine; Novo 5 ASA; Novo5 ASA; Schering Plough Brand of Mesalamine; m Aminosalicylic Acid; meta Aminosalicylic Acid; 5-Aminosalicylate
Relationship Network
Drug Context: Research Results